HUIZENGA THEODORE ALAN (SVP, Chief Accounting Officer) sold 3.9% of their position (970.00 shares) of ULTRAGENYX PHARMACEUTICAL INC. on the open market
Open‑market sale worth $36.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 9/6/2023ACC: 0001209191-23-048489
Officer· SVP, Chief Accounting Officer
Since Mar 2026
-970.00
Net shares
Net seller
$36.0K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
970.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−883.00
Price / share
$37.04
Trade value
$32.71K
% of position
3.6%
9/1/2023
24.75K→23.86K
Common Stock
Direct
Shares
−87.00
Price / share
$38.23
Trade value
$3.33K
% of position
0.4%
9/1/2023
23.86K→23.78K
Total
Net shares
−970.00
Net value
-$36.03K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/1/2023 | S · Sale | −883.00 | $37.04 | $32.71K | 3.6% | 24.75K | 23.86K |
| Common Stock Direct | 9/1/2023 | S · Sale | −87.00 | $38.23 | $3.33K | 0.4% | 23.86K | 23.78K |
| Total | −970.00 | -$36.03K | ||||||
Derivative Transactions0
No derivative transactions reported